Vivani Medical, Inc. (NASDAQ: VANI) Stock Competitors & Peer Comparison
See VANI's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for VANI and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| VANI | $1.28 | -7.91% | 75.6M | -3.20 | -$0.40 | N/A |
| ABT | $103.10 | +2.33% | 179.6B | 19.79 | $5.21 | +2.40% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $330.25 | +3.54% | 126.6B | 24.67 | $13.39 | +1.06% |
| ISRG | $337.50 | +1.65% | 119.5B | 35.08 | $9.62 | N/A |
| MDT | $83.21 | +1.46% | 106.5B | 15.05 | $5.53 | +3.42% |
| BSX | $44.25 | +1.54% | 65.8B | 14.28 | $3.10 | N/A |
| EW | $82.63 | -1.42% | 47.6B | 30.60 | $2.70 | N/A |
| RMD | $195.27 | +1.76% | 28.3B | 18.14 | $10.77 | +1.22% |
| DXCM | $71.54 | +1.50% | 27.6B | 30.70 | $2.33 | N/A |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
VANI vs ABT Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, ABT has a market cap of 179.6B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while ABT trades at $103.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas ABT's P/E ratio is 19.79. In terms of profitability, VANI's ROE is -2.64%, compared to ABT's ROE of +0.11%. Regarding short-term risk, VANI is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for VANI.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
VANI vs BSX-PA Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, VANI's ROE is -2.64%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, VANI is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for VANI.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
VANI vs SYK Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, SYK has a market cap of 126.6B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while SYK trades at $330.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas SYK's P/E ratio is 24.67. In terms of profitability, VANI's ROE is -2.64%, compared to SYK's ROE of +0.15%. Regarding short-term risk, VANI is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for VANI.Check SYK's competition here
Intuitive Surgical, Inc. (NASDAQ: ISRG)
VANI vs ISRG Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, ISRG has a market cap of 119.5B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while ISRG trades at $337.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas ISRG's P/E ratio is 35.08. In terms of profitability, VANI's ROE is -2.64%, compared to ISRG's ROE of +0.18%. Regarding short-term risk, VANI is more volatile compared to ISRG. This indicates higher risk in terms of short-term price fluctuations for VANI.Check ISRG's competition here
Medtronic plc (NYSE: MDT)
VANI vs MDT Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, MDT has a market cap of 106.5B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while MDT trades at $83.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas MDT's P/E ratio is 15.05. In terms of profitability, VANI's ROE is -2.64%, compared to MDT's ROE of +0.10%. Regarding short-term risk, VANI is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for VANI.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
VANI vs BSX Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, BSX has a market cap of 65.8B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while BSX trades at $44.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas BSX's P/E ratio is 14.28. In terms of profitability, VANI's ROE is -2.64%, compared to BSX's ROE of +0.15%. Regarding short-term risk, VANI is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for VANI.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
VANI vs EW Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, EW has a market cap of 47.6B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while EW trades at $82.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas EW's P/E ratio is 30.60. In terms of profitability, VANI's ROE is -2.64%, compared to EW's ROE of +0.10%. Regarding short-term risk, VANI is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for VANI.Check EW's competition here
ResMed Inc. (NYSE: RMD)
VANI vs RMD Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, RMD has a market cap of 28.3B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while RMD trades at $195.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas RMD's P/E ratio is 18.14. In terms of profitability, VANI's ROE is -2.64%, compared to RMD's ROE of +0.24%. Regarding short-term risk, VANI is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for VANI.Check RMD's competition here
DexCom, Inc. (NASDAQ: DXCM)
VANI vs DXCM Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, DXCM has a market cap of 27.6B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while DXCM trades at $71.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas DXCM's P/E ratio is 30.70. In terms of profitability, VANI's ROE is -2.64%, compared to DXCM's ROE of +0.34%. Regarding short-term risk, VANI is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for VANI.Check DXCM's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
VANI vs ZBH Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, ZBH has a market cap of 17.7B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while ZBH trades at $91.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas ZBH's P/E ratio is 10.77. In terms of profitability, VANI's ROE is -2.64%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, VANI is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for VANI.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
VANI vs ABMD Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas ABMD's P/E ratio is 65.36. In terms of profitability, VANI's ROE is -2.64%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, VANI is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for VANI.Check ABMD's competition here
Smith & Nephew plc (NYSE: SNN)
VANI vs SNN Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, SNN has a market cap of 12.9B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while SNN trades at $30.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas SNN's P/E ratio is 16.52. In terms of profitability, VANI's ROE is -2.64%, compared to SNN's ROE of +0.12%. Regarding short-term risk, VANI is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for VANI.Check SNN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
VANI vs SWAV Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas SWAV's P/E ratio is 78.76. In terms of profitability, VANI's ROE is -2.64%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, VANI is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for VANI.Check SWAV's competition here
Penumbra, Inc. (NYSE: PEN)
VANI vs PEN Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, PEN has a market cap of 12.5B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while PEN trades at $318.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas PEN's P/E ratio is 83.20. In terms of profitability, VANI's ROE is -2.64%, compared to PEN's ROE of +0.12%. Regarding short-term risk, VANI is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for VANI.Check PEN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
VANI vs ALGN Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, ALGN has a market cap of 12B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while ALGN trades at $167.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas ALGN's P/E ratio is 15.22. In terms of profitability, VANI's ROE is -2.64%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, VANI is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for VANI.Check ALGN's competition here
Insulet Corp. (NASDAQ: PODD)
VANI vs PODD Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, PODD has a market cap of 11.3B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while PODD trades at $163.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas PODD's P/E ratio is 30.35. In terms of profitability, VANI's ROE is -2.64%, compared to PODD's ROE of +0.21%. Regarding short-term risk, VANI is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for VANI.Check PODD's competition here
Globus Medical, Inc. (NYSE: GMED)
VANI vs GMED Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, GMED has a market cap of 10.3B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while GMED trades at $76.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas GMED's P/E ratio is 17.22. In terms of profitability, VANI's ROE is -2.64%, compared to GMED's ROE of +0.13%. Regarding short-term risk, VANI is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for VANI.Check GMED's competition here
Masimo Corporation (NASDAQ: MASI)
VANI vs MASI Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas MASI's P/E ratio is 44.43. In terms of profitability, VANI's ROE is -2.64%, compared to MASI's ROE of +0.09%. Regarding short-term risk, VANI is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for VANI.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
VANI vs BRKR Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, BRKR has a market cap of 9.2B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while BRKR trades at $60.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas BRKR's P/E ratio is 33.21. In terms of profitability, VANI's ROE is -2.64%, compared to BRKR's ROE of -0.01%. Regarding short-term risk, VANI is more volatile compared to BRKR. This indicates higher risk in terms of short-term price fluctuations for VANI.Check BRKR's competition here
Glaukos Corporation (NYSE: GKOS)
VANI vs GKOS Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, GKOS has a market cap of 9B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while GKOS trades at $153.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas GKOS's P/E ratio is -178.66. In terms of profitability, VANI's ROE is -2.64%, compared to GKOS's ROE of -0.26%. Regarding short-term risk, VANI is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for VANI.Check GKOS's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
VANI vs BIO-B Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, BIO-B has a market cap of 8.9B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while BIO-B trades at $336.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas BIO-B's P/E ratio is 99.94. In terms of profitability, VANI's ROE is -2.64%, compared to BIO-B's ROE of +0.02%. Regarding short-term risk, VANI is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for VANI.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
VANI vs BIO Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, BIO has a market cap of 8.5B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while BIO trades at $314.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas BIO's P/E ratio is 33.95. In terms of profitability, VANI's ROE is -2.64%, compared to BIO's ROE of +0.02%. Regarding short-term risk, VANI is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for VANI.Check BIO's competition here
Inari Medical, Inc. (NASDAQ: NARI)
VANI vs NARI Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas NARI's P/E ratio is -59.24. In terms of profitability, VANI's ROE is -2.64%, compared to NARI's ROE of -0.00%. Regarding short-term risk, VANI is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for VANI.Check NARI's competition here
LivaNova PLC (NASDAQ: LIVN)
VANI vs LIVN Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, LIVN has a market cap of 4.3B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while LIVN trades at $78.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas LIVN's P/E ratio is 19.55. In terms of profitability, VANI's ROE is -2.64%, compared to LIVN's ROE of +0.09%. Regarding short-term risk, VANI is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for VANI.Check LIVN's competition here
Axonics, Inc. (NASDAQ: AXNX)
VANI vs AXNX Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas AXNX's P/E ratio is -709.80. In terms of profitability, VANI's ROE is -2.64%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, VANI is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for VANI.Check AXNX's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
VANI vs IRTC Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, IRTC has a market cap of 3.6B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while IRTC trades at $109.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas IRTC's P/E ratio is -195.00. In terms of profitability, VANI's ROE is -2.64%, compared to IRTC's ROE of -0.21%. Regarding short-term risk, VANI is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for VANI.Check IRTC's competition here
Integer Holdings Corporation (NYSE: ITGR)
VANI vs ITGR Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, ITGR has a market cap of 3.4B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while ITGR trades at $98.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas ITGR's P/E ratio is 15.67. In terms of profitability, VANI's ROE is -2.64%, compared to ITGR's ROE of +0.08%. Regarding short-term risk, VANI is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for VANI.Check ITGR's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
VANI vs ESTA Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, ESTA has a market cap of 2.7B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while ESTA trades at $92.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas ESTA's P/E ratio is -64.11. In terms of profitability, VANI's ROE is -2.64%, compared to ESTA's ROE of -2.26%. Regarding short-term risk, VANI is more volatile compared to ESTA. This indicates higher risk in terms of short-term price fluctuations for VANI.Check ESTA's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
VANI vs TMDX Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, TMDX has a market cap of 2.5B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while TMDX trades at $72.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas TMDX's P/E ratio is 29.49. In terms of profitability, VANI's ROE is -2.64%, compared to TMDX's ROE of +0.42%. Regarding short-term risk, VANI is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for VANI.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
VANI vs AXGN Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, AXGN has a market cap of 2.1B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while AXGN trades at $39.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas AXGN's P/E ratio is 103.92. In terms of profitability, VANI's ROE is -2.64%, compared to AXGN's ROE of -0.21%. Regarding short-term risk, VANI is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for VANI.Check AXGN's competition here
NuVasive, Inc. (NASDAQ: NUVA)
VANI vs NUVA Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas NUVA's P/E ratio is 75.00. In terms of profitability, VANI's ROE is -2.64%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, VANI is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for VANI.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
VANI vs NVCR Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, NVCR has a market cap of 2B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while NVCR trades at $17.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas NVCR's P/E ratio is -11.54. In terms of profitability, VANI's ROE is -2.64%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, VANI is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for VANI.Check NVCR's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
VANI vs UFPT Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, UFPT has a market cap of 1.8B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while UFPT trades at $237.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas UFPT's P/E ratio is 24.71. In terms of profitability, VANI's ROE is -2.64%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, VANI is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for VANI.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
VANI vs BFLY Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, BFLY has a market cap of 1.7B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while BFLY trades at $6.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas BFLY's P/E ratio is -27.35. In terms of profitability, VANI's ROE is -2.64%, compared to BFLY's ROE of -0.37%. Regarding short-term risk, VANI is more volatile compared to BFLY. This indicates higher risk in terms of short-term price fluctuations for VANI.Check BFLY's competition here
Enovis Corporation (NYSE: ENOV)
VANI vs ENOV Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, ENOV has a market cap of 1.6B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while ENOV trades at $27.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas ENOV's P/E ratio is 8.00. In terms of profitability, VANI's ROE is -2.64%, compared to ENOV's ROE of -0.60%. Regarding short-term risk, VANI is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for VANI.Check ENOV's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
VANI vs IART Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, IART has a market cap of 1.5B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while IART trades at $19.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas IART's P/E ratio is 8.39. In terms of profitability, VANI's ROE is -2.64%, compared to IART's ROE of -0.48%. Regarding short-term risk, VANI is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for VANI.Check IART's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
VANI vs AHCO Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, AHCO has a market cap of 1.5B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while AHCO trades at $10.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas AHCO's P/E ratio is 24.45. In terms of profitability, VANI's ROE is -2.64%, compared to AHCO's ROE of -0.05%. Regarding short-term risk, VANI is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for VANI.Check AHCO's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
VANI vs INSP Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, INSP has a market cap of 1.4B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while INSP trades at $49.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas INSP's P/E ratio is 19.07. In terms of profitability, VANI's ROE is -2.64%, compared to INSP's ROE of +0.18%. Regarding short-term risk, VANI is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for VANI.Check INSP's competition here
Heska Corporation (NASDAQ: HSKA)
VANI vs HSKA Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas HSKA's P/E ratio is -62.49. In terms of profitability, VANI's ROE is -2.64%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, VANI is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for VANI.Check HSKA's competition here
CONMED Corporation (NYSE: CNMD)
VANI vs CNMD Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, CNMD has a market cap of 1.3B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while CNMD trades at $42.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas CNMD's P/E ratio is 9.39. In terms of profitability, VANI's ROE is -2.64%, compared to CNMD's ROE of +0.05%. Regarding short-term risk, VANI is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for VANI.Check CNMD's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
VANI vs ATEC Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, ATEC has a market cap of 1.3B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while ATEC trades at $8.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas ATEC's P/E ratio is -75.09. In terms of profitability, VANI's ROE is -2.64%, compared to ATEC's ROE of -4.43%. Regarding short-term risk, VANI is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for VANI.Check ATEC's competition here
Artivion, Inc. (NYSE: AORT)
VANI vs AORT Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, AORT has a market cap of 1.2B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while AORT trades at $25.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas AORT's P/E ratio is 38.91. In terms of profitability, VANI's ROE is -2.64%, compared to AORT's ROE of +0.03%. Regarding short-term risk, VANI is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for VANI.Check AORT's competition here
IRadimed Corporation (NASDAQ: IRMD)
VANI vs IRMD Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, IRMD has a market cap of 1.2B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while IRMD trades at $94.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas IRMD's P/E ratio is 47.48. In terms of profitability, VANI's ROE is -2.64%, compared to IRMD's ROE of +0.24%. Regarding short-term risk, VANI is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for VANI.Check IRMD's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
VANI vs TNDM Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, TNDM has a market cap of 1.2B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while TNDM trades at $17.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas TNDM's P/E ratio is -15.56. In terms of profitability, VANI's ROE is -2.64%, compared to TNDM's ROE of -0.68%. Regarding short-term risk, VANI is more volatile compared to TNDM. This indicates higher risk in terms of short-term price fluctuations for VANI.Check TNDM's competition here
Avanos Medical, Inc. (NYSE: AVNS)
VANI vs AVNS Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas AVNS's P/E ratio is 27.77. In terms of profitability, VANI's ROE is -2.64%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, VANI is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for VANI.Check AVNS's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
VANI vs SILK Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas SILK's P/E ratio is -18.96. In terms of profitability, VANI's ROE is -2.64%, compared to SILK's ROE of -0.35%. Regarding short-term risk, VANI is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for VANI.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
VANI vs FNA Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas FNA's P/E ratio is -19.83. In terms of profitability, VANI's ROE is -2.64%, compared to FNA's ROE of -0.35%. Regarding short-term risk, VANI is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for VANI.Check FNA's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
VANI vs LMRI Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while LMRI trades at $10.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas LMRI's P/E ratio is -21.27. In terms of profitability, VANI's ROE is -2.64%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, VANI is more volatile compared to LMRI. This indicates higher risk in terms of short-term price fluctuations for VANI.Check LMRI's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
VANI vs PRCT Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, PRCT has a market cap of 950M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while PRCT trades at $16.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas PRCT's P/E ratio is -9.17. In terms of profitability, VANI's ROE is -2.64%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, VANI is more volatile compared to PRCT. This indicates higher risk in terms of short-term price fluctuations for VANI.Check PRCT's competition here
InMode Ltd. (NASDAQ: INMD)
VANI vs INMD Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, INMD has a market cap of 872M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while INMD trades at $15.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas INMD's P/E ratio is 9.72. In terms of profitability, VANI's ROE is -2.64%, compared to INMD's ROE of +0.13%. Regarding short-term risk, VANI is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for VANI.Check INMD's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
VANI vs CSII Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas CSII's P/E ratio is -20.83. In terms of profitability, VANI's ROE is -2.64%, compared to CSII's ROE of -0.14%. Regarding short-term risk, VANI is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for VANI.Check CSII's competition here
Bioventus Inc. (NASDAQ: BVS)
VANI vs BVS Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, BVS has a market cap of 799.4M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while BVS trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas BVS's P/E ratio is 15.73. In terms of profitability, VANI's ROE is -2.64%, compared to BVS's ROE of +0.16%. Regarding short-term risk, VANI is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for VANI.Check BVS's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
VANI vs SIBN Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, SIBN has a market cap of 737.1M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while SIBN trades at $16.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas SIBN's P/E ratio is -42.62. In terms of profitability, VANI's ROE is -2.64%, compared to SIBN's ROE of -0.10%. Regarding short-term risk, VANI is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for VANI.Check SIBN's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
VANI vs SSII Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, SSII has a market cap of 695.5M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while SSII trades at $3.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas SSII's P/E ratio is -67.78. In terms of profitability, VANI's ROE is -2.64%, compared to SSII's ROE of -0.23%. Regarding short-term risk, VANI is more volatile compared to SSII. This indicates higher risk in terms of short-term price fluctuations for VANI.Check SSII's competition here
CeriBell, Inc. (NASDAQ: CBLL)
VANI vs CBLL Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, CBLL has a market cap of 641.6M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while CBLL trades at $16.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas CBLL's P/E ratio is -10.37. In terms of profitability, VANI's ROE is -2.64%, compared to CBLL's ROE of -0.38%. Regarding short-term risk, VANI is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for VANI.Check CBLL's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
VANI vs BWAY Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, BWAY has a market cap of 626.4M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while BWAY trades at $15.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas BWAY's P/E ratio is 40.57. In terms of profitability, VANI's ROE is -2.64%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, VANI is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for VANI.Check BWAY's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
VANI vs TCMD Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, TCMD has a market cap of 619.8M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while TCMD trades at $27.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas TCMD's P/E ratio is 31.23. In terms of profitability, VANI's ROE is -2.64%, compared to TCMD's ROE of +0.10%. Regarding short-term risk, VANI is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for VANI.Check TCMD's competition here
Surmodics, Inc. (NASDAQ: SRDX)
VANI vs SRDX Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas SRDX's P/E ratio is -34.66. In terms of profitability, VANI's ROE is -2.64%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, VANI is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for VANI.Check SRDX's competition here
Cerus Corporation (NASDAQ: CERS)
VANI vs CERS Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, CERS has a market cap of 587.1M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while CERS trades at $2.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas CERS's P/E ratio is -58.48. In terms of profitability, VANI's ROE is -2.64%, compared to CERS's ROE of -0.15%. Regarding short-term risk, VANI is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for VANI.Check CERS's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
VANI vs APEN Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas APEN's P/E ratio is -9.43. In terms of profitability, VANI's ROE is -2.64%, compared to APEN's ROE of -0.85%. Regarding short-term risk, VANI is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for VANI.Check APEN's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
VANI vs CTKB Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, CTKB has a market cap of 576M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while CTKB trades at $4.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas CTKB's P/E ratio is -34.31. In terms of profitability, VANI's ROE is -2.64%, compared to CTKB's ROE of -0.21%. Regarding short-term risk, VANI is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for VANI.Check CTKB's competition here
ZimVie Inc. (NASDAQ: ZIMV)
VANI vs ZIMV Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, VANI's ROE is -2.64%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, VANI is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for VANI.Check ZIMV's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
VANI vs NPCE Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, NPCE has a market cap of 504.9M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while NPCE trades at $14.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas NPCE's P/E ratio is -25.53. In terms of profitability, VANI's ROE is -2.64%, compared to NPCE's ROE of -1.21%. Regarding short-term risk, VANI is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for VANI.Check NPCE's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
VANI vs KIDS Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, KIDS has a market cap of 484.7M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while KIDS trades at $18.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas KIDS's P/E ratio is -18.32. In terms of profitability, VANI's ROE is -2.64%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, VANI is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for VANI.Check KIDS's competition here
Varex Imaging Corporation (NASDAQ: VREX)
VANI vs VREX Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, VREX has a market cap of 459.7M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while VREX trades at $10.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas VREX's P/E ratio is 11.49. In terms of profitability, VANI's ROE is -2.64%, compared to VREX's ROE of -0.18%. Regarding short-term risk, VANI is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for VANI.Check VREX's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
VANI vs OFIX Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, OFIX has a market cap of 454.7M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while OFIX trades at $11.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas OFIX's P/E ratio is -45.82. In terms of profitability, VANI's ROE is -2.64%, compared to OFIX's ROE of -0.13%. Regarding short-term risk, VANI is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for VANI.Check OFIX's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
VANI vs CLPT Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, CLPT has a market cap of 423.5M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while CLPT trades at $14.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas CLPT's P/E ratio is -13.98. In terms of profitability, VANI's ROE is -2.64%, compared to CLPT's ROE of -1.41%. Regarding short-term risk, VANI is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for VANI.Check CLPT's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
VANI vs PACB Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, PACB has a market cap of 422.4M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while PACB trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas PACB's P/E ratio is -2.78. In terms of profitability, VANI's ROE is -2.64%, compared to PACB's ROE of -4.88%. Regarding short-term risk, VANI is more volatile compared to PACB. This indicates higher risk in terms of short-term price fluctuations for VANI.Check PACB's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
VANI vs DCTH Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, DCTH has a market cap of 421.9M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while DCTH trades at $12.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas DCTH's P/E ratio is 1222.00. In terms of profitability, VANI's ROE is -2.64%, compared to DCTH's ROE of +0.01%. Regarding short-term risk, VANI is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for VANI.Check DCTH's competition here
Electromed, Inc. (AMEX: ELMD)
VANI vs ELMD Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, ELMD has a market cap of 318.8M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while ELMD trades at $38.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas ELMD's P/E ratio is 32.91. In terms of profitability, VANI's ROE is -2.64%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, VANI is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for VANI.Check ELMD's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
VANI vs SMLR Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas SMLR's P/E ratio is 3.92. In terms of profitability, VANI's ROE is -2.64%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, VANI is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for VANI.Check SMLR's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
VANI vs AVR Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, AVR has a market cap of 299.1M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while AVR trades at $8.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas AVR's P/E ratio is -3.65. In terms of profitability, VANI's ROE is -2.64%, compared to AVR's ROE of -1.24%. Regarding short-term risk, VANI is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for VANI.Check AVR's competition here
Carlsmed, Inc. (NASDAQ: CARL)
VANI vs CARL Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, CARL has a market cap of 293.6M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while CARL trades at $10.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas CARL's P/E ratio is -4.30. In terms of profitability, VANI's ROE is -2.64%, compared to CARL's ROE of -0.62%. Regarding short-term risk, VANI is more volatile compared to CARL. This indicates higher risk in terms of short-term price fluctuations for VANI.Check CARL's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
VANI vs SGHT Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, SGHT has a market cap of 267.2M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while SGHT trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas SGHT's P/E ratio is -6.92. In terms of profitability, VANI's ROE is -2.64%, compared to SGHT's ROE of -0.59%. Regarding short-term risk, VANI is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for VANI.Check SGHT's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
VANI vs TMCI Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, TMCI has a market cap of 259.5M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while TMCI trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas TMCI's P/E ratio is -4.26. In terms of profitability, VANI's ROE is -2.64%, compared to TMCI's ROE of -0.69%. Regarding short-term risk, VANI is more volatile compared to TMCI. This indicates higher risk in terms of short-term price fluctuations for VANI.Check TMCI's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
VANI vs MGRM Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas MGRM's P/E ratio is -12.00. In terms of profitability, VANI's ROE is -2.64%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, VANI is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for VANI.Check MGRM's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
VANI vs FOCL Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, FOCL has a market cap of 226M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while FOCL trades at $6.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas FOCL's P/E ratio is -7.75. In terms of profitability, VANI's ROE is -2.64%, compared to FOCL's ROE of -1.38%. Regarding short-term risk, VANI is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for VANI.Check FOCL's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
VANI vs CATX Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, CATX has a market cap of 224.4M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while CATX trades at $2.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas CATX's P/E ratio is -2.06. In terms of profitability, VANI's ROE is -2.64%, compared to CATX's ROE of -0.42%. Regarding short-term risk, VANI is more volatile compared to CATX. This indicates higher risk in terms of short-term price fluctuations for VANI.Check CATX's competition here
Nevro Corp. (NYSE: NVRO)
VANI vs NVRO Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas NVRO's P/E ratio is -1.91. In terms of profitability, VANI's ROE is -2.64%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, VANI is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for VANI.Check NVRO's competition here
Profound Medical Corp. (NASDAQ: PROF)
VANI vs PROF Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, PROF has a market cap of 219.7M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while PROF trades at $7.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas PROF's P/E ratio is -5.85. In terms of profitability, VANI's ROE is -2.64%, compared to PROF's ROE of -0.70%. Regarding short-term risk, VANI is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for VANI.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
VANI vs RXST Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, RXST has a market cap of 214.8M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while RXST trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas RXST's P/E ratio is -7.21. In terms of profitability, VANI's ROE is -2.64%, compared to RXST's ROE of -0.17%. Regarding short-term risk, VANI is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for VANI.Check RXST's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
VANI vs SENS Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, SENS has a market cap of 203.1M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while SENS trades at $4.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas SENS's P/E ratio is -2.43. In terms of profitability, VANI's ROE is -2.64%, compared to SENS's ROE of -1.30%. Regarding short-term risk, VANI is more volatile compared to SENS. This indicates higher risk in terms of short-term price fluctuations for VANI.Check SENS's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
VANI vs ANIK Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, ANIK has a market cap of 198.9M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while ANIK trades at $14.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas ANIK's P/E ratio is 30.51. In terms of profitability, VANI's ROE is -2.64%, compared to ANIK's ROE of -0.08%. Regarding short-term risk, VANI is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for VANI.Check ANIK's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
VANI vs BSGM Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas BSGM's P/E ratio is -5.81. In terms of profitability, VANI's ROE is -2.64%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, VANI is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for VANI.Check BSGM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
VANI vs MDGS Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas MDGS's P/E ratio is -0.27. In terms of profitability, VANI's ROE is -2.64%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, VANI is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for VANI.Check MDGS's competition here
Quanterix Corporation (NASDAQ: QTRX)
VANI vs QTRX Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, QTRX has a market cap of 172.9M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while QTRX trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas QTRX's P/E ratio is -2.29. In terms of profitability, VANI's ROE is -2.64%, compared to QTRX's ROE of -0.35%. Regarding short-term risk, VANI is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for VANI.Check QTRX's competition here
Inogen, Inc. (NASDAQ: INGN)
VANI vs INGN Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, INGN has a market cap of 166.5M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while INGN trades at $6.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas INGN's P/E ratio is -6.76. In terms of profitability, VANI's ROE is -2.64%, compared to INGN's ROE of -0.13%. Regarding short-term risk, VANI is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for VANI.Check INGN's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
VANI vs QIPT Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas QIPT's P/E ratio is -15.87. In terms of profitability, VANI's ROE is -2.64%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, VANI is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for VANI.Check QIPT's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
VANI vs TLSI Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, TLSI has a market cap of 160M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while TLSI trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas TLSI's P/E ratio is -2.51. In terms of profitability, VANI's ROE is -2.64%, compared to TLSI's ROE of +1.63%. Regarding short-term risk, VANI is more volatile compared to TLSI. This indicates higher risk in terms of short-term price fluctuations for VANI.Check TLSI's competition here
Picard Medical, Inc. (AMEX: PMI)
VANI vs PMI Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, PMI has a market cap of 137.1M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while PMI trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas PMI's P/E ratio is -0.07. In terms of profitability, VANI's ROE is -2.64%, compared to PMI's ROE of +4.99%. Regarding short-term risk, VANI is more volatile compared to PMI. This indicates higher risk in terms of short-term price fluctuations for VANI.Check PMI's competition here
CVRx, Inc. (NASDAQ: CVRX)
VANI vs CVRX Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, CVRX has a market cap of 125.8M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while CVRX trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas CVRX's P/E ratio is -2.35. In terms of profitability, VANI's ROE is -2.64%, compared to CVRX's ROE of -1.21%. Regarding short-term risk, VANI is more volatile compared to CVRX. This indicates higher risk in terms of short-term price fluctuations for VANI.Check CVRX's competition here
Avita Medical Inc. (NASDAQ: RCEL)
VANI vs RCEL Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, RCEL has a market cap of 114.5M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while RCEL trades at $4.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas RCEL's P/E ratio is -2.94. In terms of profitability, VANI's ROE is -2.64%, compared to RCEL's ROE of +3.05%. Regarding short-term risk, VANI is more volatile compared to RCEL. This indicates higher risk in terms of short-term price fluctuations for VANI.Check RCEL's competition here
iCAD, Inc. (NASDAQ: ICAD)
VANI vs ICAD Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas ICAD's P/E ratio is -20.37. In terms of profitability, VANI's ROE is -2.64%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, VANI is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for VANI.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
VANI vs HJLI Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas HJLI's P/E ratio is N/A. In terms of profitability, VANI's ROE is -2.64%, compared to HJLI's ROE of -0.66%. Regarding short-term risk, VANI is more volatile compared to HJLI. This indicates higher risk in terms of short-term price fluctuations for VANI.Check HJLI's competition here
Solana Company (NASDAQ: HSDT)
VANI vs HSDT Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, HSDT has a market cap of 95.2M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while HSDT trades at $1.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas HSDT's P/E ratio is -0.01. In terms of profitability, VANI's ROE is -2.64%, compared to HSDT's ROE of -1.55%. Regarding short-term risk, VANI is more volatile compared to HSDT. This indicates higher risk in terms of short-term price fluctuations for VANI.Check HSDT's competition here
Owlet, Inc. (NYSE: OWLT)
VANI vs OWLT Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, OWLT has a market cap of 95M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while OWLT trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas OWLT's P/E ratio is -37.50. In terms of profitability, VANI's ROE is -2.64%, compared to OWLT's ROE of +11.36%. Regarding short-term risk, VANI is more volatile compared to OWLT. This indicates higher risk in terms of short-term price fluctuations for VANI.Check OWLT's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
VANI vs ASXC Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas ASXC's P/E ratio is -1.12. In terms of profitability, VANI's ROE is -2.64%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, VANI is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for VANI.Check ASXC's competition here
SkinHealth Systems Inc. (NASDAQ: SKIN)
VANI vs SKIN Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, SKIN has a market cap of 94.9M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while SKIN trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas SKIN's P/E ratio is -4.31. In terms of profitability, VANI's ROE is -2.64%, compared to SKIN's ROE of -0.09%. Regarding short-term risk, VANI is more volatile compared to SKIN. This indicates higher risk in terms of short-term price fluctuations for VANI.Check SKIN's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
VANI vs LUCD Comparison July 2026
Vivani Medical, Inc. (NASDAQ: VANI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 75.6M. In comparison, LUCD has a market cap of 92.9M. Regarding current trading prices, VANI is priced at $1.28 on the NASDAQ, while LUCD trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.20, whereas LUCD's P/E ratio is -2.45. In terms of profitability, VANI's ROE is -2.64%, compared to LUCD's ROE of -3.70%. Regarding short-term risk, VANI is more volatile compared to LUCD. This indicates higher risk in terms of short-term price fluctuations for VANI.Check LUCD's competition here